PRA Health Sciences

Side-by-side with our clients, we strive to move drug discovery forward, helping them to develop life-saving and life-improving drugs. PRA has more than 12,000 employees working in 80+ countries providing comprehensive clinical development services across all phases. From full service clinical development to the pioneering Embedded Solutions™ model, PRA provides a broad spectrum of solutions that meet the demands of a diverse marketplace. As a top five CRO, we have worked on 100+ marketed drugs across several therapeutic areas and conducted the pivotal or supportive trials that led to FDA and/or international regulatory approval of 50+ such drugs.

Raleigh, US
Size (employees)
13,000 (est)+9%
PRA Health Sciences was founded in 1976 and is headquartered in Raleigh, US

PRA Health Sciences Office Locations

PRA Health Sciences has an office in Raleigh
Raleigh, US (HQ)
400 4130 Parklake Ave

PRA Health Sciences Metrics

PRA Health Sciences Financial Metrics

PRA Health Sciences's revenue was reported to be $1.8 b in FY, 2016 which is a 12% increase from the previous period.

Revenue (FY, 2016)

$1.8 b

Revenue growth (FY, 2015 - FY, 2016), %


Net income (FY, 2016)

$68.2 m

EBIT (FY, 2016)

$162.3 m

Market capitalization (23-May-2017)

$4.5 b

Closing share price (23-May-2017)


Cash (31-Dec-2016)

$144.6 m
PRA Health Sciences's current market capitalization is $4.5 b.
FY, 2015FY, 2016


$1.6 b$1.8 b

Revenue growth, %


General and administrative expense

$69.7 m$269.9 m

Operating expense total

$69.7 m$269.9 m


($22.7 m)$162.3 m

EBIT margin, %


Interest expense

($23.7 m)($54.9 m)

Income tax expense

($17.2 m)$28.5 m

Net Income

($39.9 m)$68.2 m
FY, 2015FY, 2016


$121.1 m$144.6 m


$30.2 m$35.4 m

Current Assets

$573.8 m$624.7 m


$1 b$972 m

Total Assets

$2.2 b$2.2 b

Accounts Payable

$57.1 m$51.3 m

Current Liabilities

$530 m$564.2 m

Additional Paid-in Capital

$828.3 m$879.1 m

Retained Earnings

$6.1 m$74.3 m

Total Equity

$702.7 m$729.3 m

Financial Leverage

3.2 x3 x
FY, 2015FY, 2016

Net Income

($39.9 m)$68.2 m

Depreciation and Amortization

$25.3 m$69.5 m

Accounts Payable

($46.2 m)($1.5 m)

Cash From Operating Activities

$35.9 m$160 m

Purchases of PP&E

($4.9 m)($33.1 m)

Cash From Investing Activities

($1 b)($34.6 m)

Long-term Borrowings

($567.1 m)($822.6 m)

Cash From Financing Activities

$1.1 b($101.6 m)

Income Taxes Paid

$3.1 m$7.3 m
Y, 2016


$151 k

Financial Leverage

3 x

PRA Health Sciences Market Value History

PRA Health Sciences Revenue Breakdown

PRA Health Sciences Online Presence

PRA Health Sciences News

PRA Health Sciences Company Life

You may also be interested in